{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:07:56Z","timestamp":1791295676154,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,24]],"date-time":"2014-04-24T00:00:00Z","timestamp":1398297600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s10875-014-0037-0","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T07:03:14Z","timestamp":1398236594000},"page":"663-668","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":68,"title":["Early Systemic Sclerosis: Serum Profiling of Factors Involved in Endothelial, T-cell, and Fibroblast Interplay is Marked by Elevated Interleukin-33 Levels"],"prefix":"10.1007","volume":"34","author":[{"given":"Serena","family":"Vettori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Iudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"D\u2019Abrosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Giacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giusi","family":"Barra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Palma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,24]]},"reference":[{"key":"37_CR1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semarthrit.2007.10.010","volume":"38","author":"YS Gu","year":"2008","unstructured":"Gu YS, Kong J, Cheema GS, Keen CL, Wick G, Gershwin ME. The immunobiology of systemic sclerosis. Semin Arthritis Rheum. 2008;38:132\u201360.","journal-title":"Semin Arthritis Rheum"},{"key":"37_CR2","first-page":"381","volume":"154","author":"R Fleischmajer","year":"1984","unstructured":"Fleischmajer R, Perlish JS. The pathophysiology of the fibrosis in scleroderma skin. Prog Clin Biol Res. 1984;154:381\u2013404.","journal-title":"Prog Clin Biol Res"},{"key":"37_CR3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11926-012-0297-8","volume":"15","author":"MB Greenblatt","year":"2013","unstructured":"Greenblatt MB, Aliprantis AO. The immune pathogenesis of scleroderma: context is everything. Curr Rheumatol Rep. 2013;15:297.","journal-title":"Curr Rheumatol Rep"},{"key":"37_CR4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/rheumatology\/keq094","volume":"49","author":"R Palma De","year":"2010","unstructured":"De Palma R, D\u2019Aiuto E, Vettori S, Cuoppolo PP, Abbate G, Valentini G. Peripheral T cells from early systemic sclerosis patients kill autologous fibroblasts in co-culture: is T-cell response aimed to play a protective role? Rheumatology (Oxford). 2010;49:1257\u201366.","journal-title":"Rheumatology (Oxford)"},{"key":"37_CR5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/rheumatology\/keq176","volume":"50","author":"G Valentini","year":"2011","unstructured":"Valentini G, Cuomo G, Abignano G, Petrillo A, Vettori S, Capasso A, et al. Early systemic sclerosis: assessment of clinical and pre-clinical organ ivolvement in patients with different disease features. Rheumatology (Oxford). 2011;50:317\u201323.","journal-title":"Rheumatology (Oxford)"},{"key":"37_CR6","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1186\/ar4236","volume":"15","author":"G Valentini","year":"2013","unstructured":"Valentini G, Marcoccia A, Cuomo G, Vettori S, Iudici M, Bondanini F, et al. Early systemic sclerosis: marker autoantibodies and videocapillaroscopy patterns are each associated with distinct clinical, functional and cellular activation markers. Arthritis Res Ther. 2013;15:R63.","journal-title":"Arthritis Res Ther"},{"key":"37_CR7","doi-asserted-by":"crossref","unstructured":"Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581\u201390","DOI":"10.1002\/art.1780230510"},{"key":"37_CR8","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F Hoogen Van den","year":"2013","unstructured":"Van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347.","journal-title":"Arthritis Rheum"},{"key":"37_CR9","first-page":"202","volume":"15","author":"EC LeRoy","year":"1988","unstructured":"LeRoy EC, Black CM, Fleichmajer R, Jablonksa S, Krieg T, Medsger Jr TA, et al. Scleroderma (systemic sclerosis). Classification, subset and pathogenesis. J Rheumatol. 1988;15:202\u20135.","journal-title":"J Rheumatol"},{"key":"37_CR10","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.semarthrit.2011.07.010","volume":"41","author":"S Cappelli","year":"2012","unstructured":"Cappelli S, Bellando Randone S, Martinovic D, Tamas MM, Pasalic K, Allanore Y, et al. \u201cTo be or not to be,\u201d ten years after: evidence for mixed connective tissue disease as a distinct entity. Semin Arthritis Rheum. 2012;41:589\u201398.","journal-title":"Semin Arthritis Rheum"},{"key":"37_CR11","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.4049\/jimmunol.0901778","volume":"185","author":"A Yoshizaki","year":"2010","unstructured":"Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, Akiyama Y, et al. Cell adhesion molecole regulate fibrotic process via Th1\/Th2\/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol. 2010;185:2502\u201315.","journal-title":"J Immunol"},{"key":"37_CR12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1136\/ard.2010.137349","volume":"70","author":"V Codullo","year":"2011","unstructured":"Codullo V, Baldwin HM, Singh MD, Fraser AR, Wilson C, Gilmour A, et al. An investigation of the inflammatory cytokine and chemokine network in systemic sclerosis. Ann Rheum Dis. 2011;70:1115\u201321.","journal-title":"Ann Rheum Dis"},{"key":"37_CR13","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.cyto.2011.08.030","volume":"56","author":"P Fuschiotti","year":"2011","unstructured":"Fuschiotti P. Role of IL-13 in systemic sclerosis. Cytokine. 2011;56:544\u20139.","journal-title":"Cytokine"},{"key":"37_CR14","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.4049\/jimmunol.0903306","volume":"184","author":"AL Rankin","year":"2010","unstructured":"Rankin AL, Mumm JB, Murphy E, Turner S, Yu N, McClanahan TK, et al. IL-33 induces IL-13-dependent cutaneous fibrosis. J Immunol. 2010;184:1526\u201335.","journal-title":"J Immunol"},{"key":"37_CR15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2741\/s22","volume":"1","author":"J Varga","year":"2009","unstructured":"Varga J, Whitfield ML. Transforming growth factor-beta in systemic sclerosis (scleroderma). Front Biosci (Schol Ed). 2009;1:226\u201335.","journal-title":"Front Biosci (Schol Ed)"},{"key":"37_CR16","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10067-004-0987-3","volume":"24","author":"A Kuryliszyn-Moskal","year":"2005","unstructured":"Kuryliszyn-Moskal A, Klimiuk PA, Sierakowski S. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement. Clin Rheumatol. 2005;24:111\u20136.","journal-title":"Clin Rheumatol"},{"key":"37_CR17","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/rheumatology\/34.11.1048","volume":"34","author":"CP Denton","year":"1995","unstructured":"Denton CP, Bickerstaff MC, Shiwen X, Carulli MT, Haskard DO, Dubois RM, et al. Serial circulating adhesion molecule levels reflect disease severity in systemic sclerosis. Br J Rheumatol. 1995;34:1048\u201354.","journal-title":"Br J Rheumatol"},{"key":"37_CR18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1136\/ard.53.11.763","volume":"53","author":"N Snowden","year":"1994","unstructured":"Snowden N, Coupes B, Herrick A, Illingworth K, Jayson MI, Brenchley PE. Plasma TGF-beta in systemic sclerosis: a cross sectional study. Ann Rheum Dis. 1994;53:763\u20137.","journal-title":"Ann Rheum Dis"},{"key":"37_CR19","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/rheumatology\/kei088","volume":"44","author":"M Dziadzio","year":"2005","unstructured":"Dziadzio M, Smith RE, Abraham DJ, Black CM, Denton CP. Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score. Rheumatology (Oxford). 2005;44:1518\u201324.","journal-title":"Rheumatology (Oxford)"},{"key":"37_CR20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2013.05.002","volume":"59","author":"SI Wolf","year":"2013","unstructured":"Wolf SI, Howat S, Abraham DJ, Pearson JD, Lawson C. Agonistic anti-ICAM-1 antibodies in scleroderma: activation of endothelial pro-inflammatory cascade. Vasc Pharmacol. 2013;59:19\u201326.","journal-title":"Vasc Pharmacol"},{"key":"37_CR21","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1160\/TH07-01-0040","volume":"97","author":"B Mehrad","year":"2007","unstructured":"Mehrad B, Keane MP, Strieter RM. Chemokines as mediators of angiogenesis. Thromb Haemost. 2007;97:755\u201362.","journal-title":"Thromb Haemost"},{"key":"37_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/path.2277","volume":"241","author":"T Wynn","year":"2008","unstructured":"Wynn T. Cellular and molecular mechanisms of fibrosis. J Pathol. 2008;241:199\u2013210.","journal-title":"J Pathol"},{"key":"37_CR23","first-page":"167","volume":"4","author":"FL Veerdonk Van de","year":"2013","unstructured":"Van de Veerdonk FL, Netea MG. New insights in the immunobiology of IL-1 family members. Front Immunol. 2013;4:167.","journal-title":"Front Immunol"},{"key":"37_CR24","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.immuni.2005.09.015","volume":"23","author":"J Schmitz","year":"2005","unstructured":"Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479\u201390.","journal-title":"Immunity"},{"key":"37_CR25","doi-asserted-by":"crossref","unstructured":"Chackarian AA, Oldham ER, Murphy EE, Schimtz J, Pflanz S, Kastelein RA, et al. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol. 2007;179:2551\u20135.","DOI":"10.4049\/jimmunol.179.4.2551"},{"key":"37_CR26","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1136\/ard.2010.148247","volume":"70","author":"M Manetti","year":"2011","unstructured":"Manetti M, Guiducci S, Ceccarelli C, Romano E, Bellando-Randone S, Conforti ML, et al. Increased circulating levels of interleukin 33 in sistemic sclerosis correlate with early disease stage and microvascular involvement. Ann Rheum Dis. 2011;70:1876\u20138.","journal-title":"Ann Rheum Dis"},{"key":"37_CR27","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/annrheumdis-2012-201553","volume":"72","author":"S Terras","year":"2013","unstructured":"Terras S, Opitz E, Moritz RKC, H\u00f6xtermann S, Gambichler T, Kreuter A. Increased serum IL-33 levels may indicate vascular involvement in systemic sclerosis. Ann Rheum Dis. 2013;72:144\u20135.","journal-title":"Ann Rheum Dis"},{"key":"37_CR28","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.2009.119321","volume":"69","author":"M Manetti","year":"2010","unstructured":"Manetti M, Ibba-Manneschi L, Liakouli V, Guiducci S, Milia AF, Benelli G, et al. The IL1-like cytokine IL-33 and its receptor ST2 are abnormally espresse in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis. 2010;69:598\u2013605.","journal-title":"Ann Rheum Dis"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0037-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-014-0037-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-014-0037-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T20:29:19Z","timestamp":1565382559000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-014-0037-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,24]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["37"],"URL":"https:\/\/doi.org\/10.1007\/s10875-014-0037-0","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,24]]}}}